INO – inovio pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $8.00 to $7.00. They now have a "sector perform" rating on the stock.
INOVIO Reports Inducement Grants Under Inducement Plan
INOVIO to Present at Upcoming Scientific Conferences
INOVIO to Present at Upcoming Scientific Conference
Form SC 13G INOVIO PHARMACEUTICALS, Filed by: BlackRock, Inc.
Form 424B5 INOVIO PHARMACEUTICALS,
Form 8-K INOVIO PHARMACEUTICALS, For: Aug 13
Form 8-K INOVIO PHARMACEUTICALS, For: Aug 08
Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.